Answers are grounded in this paper and cite their sources.
Shows leptin replacement improves metabolic abnormalities in sisters, indicating effective hormonal therapy.
(OBX2, age 24). Total body fat mass decreased, serum lipids normalized, and insulin sensitivity improved. Hypogonadotropic hypogonadism reversed, and menstruation resumed. Thus, metreleptin reversed the major metabolic and endocrine abnormalities associated with leptin deficiency in these sisters. Limitations include the small sample size, absence of a control group, and lack of anti-metreleptin antibody measurements. Nevertheless, our findings support that leptin replacement with metreleptin is currently the only effective hormonal treatment for this monogenic form of human obesity.
No takes yet. Share an insight, caveat, or question.
Yupanqui-Lozno et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: